Literature DB >> 26932151

Catheter-measured Hemodynamics of Adult Fontan Circulation: Associations with Adverse Event and End-organ Dysfunctions.

Makoto Mori1, Camden Hebson2, Kayoko Shioda3, Robert W Elder4, Brian E Kogon5, Fred H Rodriguez2, Maan Jokhadar2, Wendy M Book2.   

Abstract

BACKGROUND: In heart failure, a high systemic vascular resistance index (SVRI), high central venous pressure (CVP), and low cardiac index (CI) predict poor outcomes. Conversely, late hemodynamic manifestations of failing Fontan circulation and associations with end-organ dysfunction are not well understood.
METHODS: A retrospective review of right-heart catheterization data of adult Fontan patients between 2002 and 2014 was conducted. Relationships between hemodynamic variables and serious adverse events (death or heart transplant) were examined using the Cox proportional hazard analysis. Correlations between the hemodynamic measurements and signs of end-organ dysfunction (MELD-XI, Child-Pugh, VAST score, estimated glomerular filtration rate [eGFR]) were analyzed.
RESULTS: Sixty post-Fontan patients (85% systemic left ventricle, 40% atriopulmonary Fontan, mean age of 28 years, and mean time since Fontan operation of 21.9 years) were included. At baseline, those with an event were statistically younger, had lower transcutaneous oxygen saturations, were more likely to have an atriopulmonary Fontan, and were more likely to have a pacemaker. Eighteen experienced a cardiovascularly significant event. Using univariate analysis to compare the event and nonevent groups, mean CI was 2.8 ± 0.9 vs. 2.4 ± 0.5 L/min/m2 (P = .004), and CVP was 18.6 ± 6.5 vs. 16.1 ± 4.3 mmHg (P = .03). However, the statistical significances did not persist in the multivariate model. Higher CVP and pulmonary capillary wedge pressure (PCWP) were associated with higher MELD-XI and Child-Pugh scores, and the VAST score was only associated with PCWP.
CONCLUSIONS: Symptomatic adult Fontan patients who experienced an event manifested with a higher CI and CVP, although the multivariate Cox proportional hazard analysis did not yield any significant associations. The presences of hepatic dysfunction and portal venous outflow obstruction were associated with a higher CVP and PCWP. Renal dysfunction was prevalent but no statistically significant association between the hemodynamic measurements was identified, although trends toward a higher CVP and transpulmonary gradient were identified.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Adult; Fontan Circulation; Organ Dysfunction; Right-heart Catheterization

Mesh:

Year:  2016        PMID: 26932151     DOI: 10.1111/chd.12345

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  7 in total

1.  Superior Mesenteric Arterial Flow Pattern is Associated with Major Adverse Events in Adults with Fontan Circulation.

Authors:  Makoto Mori; Kayoko Shioda; Robert W Elder; Maria A Pernetz; Fred H Rodriguez; Alicia Rangosch; Brian E Kogon; Wendy M Book
Journal:  Pediatr Cardiol       Date:  2016-03-31       Impact factor: 1.655

Review 2.  Invasive Hemodynamic Evaluation of the Fontan Circulation: Current Day Practice and Limitations.

Authors:  Ashish H Shah; Shakeel A Qureshi; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2022-03-01       Impact factor: 2.931

3.  Hemodynamics of Fontan Failure: The Role of Pulmonary Vascular Disease.

Authors:  Alexander C Egbe; Heidi M Connolly; William R Miranda; Naser M Ammash; Donald J Hagler; Gruschen R Veldtman; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2017-12       Impact factor: 8.790

4.  Clinical Significance of Central Venous Pressure During Exercise After Fontan Procedure.

Authors:  Seiji Asagai; Kei Inai; Eriko Shimada; Gen Harada; Hisashi Sugiyama
Journal:  Pediatr Cardiol       Date:  2019-11-11       Impact factor: 1.655

5.  Venous congestion and pulmonary vascular function in Fontan circulation: Implications for prognosis and treatment.

Authors:  Alexander C Egbe; Yogesh N V Reddy; Arooj R Khan; Mohamad Al-Otaibi; Emmanuel Akintoye; Masaru Obokata; Barry A Borlaug
Journal:  Int J Cardiol       Date:  2018-11-15       Impact factor: 4.164

Review 6.  Where Is the "Optimal" Fontan Hemodynamics?

Authors:  Hideo Ohuchi
Journal:  Korean Circ J       Date:  2017-09-18       Impact factor: 3.243

7.  In-vitro performance of a single-chambered total artificial heart in a Fontan circulation.

Authors:  Stephan Hildebrand; Sascha Groß-Hardt; Thomas Schmitz-Rode; Ulrich Steinseifer; Sebastian Victor Jansen
Journal:  J Artif Organs       Date:  2021-05-06       Impact factor: 1.731

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.